Education
About Us
Working with TipRanks
Follow Us
Jazz Pharmaceuticals (JAZZ)
NASDAQ:JAZZ
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 4.07B | $ 3.83B | $ 3.66B | $ 3.09B | $ 2.36B |
| Gross Profit | $ 4.07B | $ 3.40B | $ 3.12B | $ 2.65B | $ 2.21B |
| Operating Income | $ 716.63M | $ 578.58M | $ 512.27M | $ 170.28M | $ 765.46M |
| EBITDA | $ 716.63M | $ 1.23B | $ 553.78M | $ 1.03B | $ 649.65M |
| Net Income | $ 560.12M | $ 414.83M | $ -214.14M | $ -328.95M | $ 238.62M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.99B | $ 1.63B | $ 881.48M | $ 591.45M | $ 2.13B |
| Total Assets | $ 12.01B | $ 11.39B | $ 10.84B | $ 12.30B | $ 6.54B |
| Total Debt | $ 69.94M | $ 5.79B | $ 5.80B | $ 6.14B | $ 2.23B |
| Net Debt | $ -2.34B | $ 4.29B | $ 4.91B | $ 5.55B | $ 1.18B |
| Total Liabilities | $ 7.92B | $ 7.66B | $ 7.75B | $ 8.33B | $ 2.88B |
| Stockholders' Equity | $ 4.09B | $ 3.74B | $ 3.09B | $ 3.97B | $ 3.66B |
| Cash Flow | |||||
| Free Cash Flow | $ 1.35B | $ 1.07B | $ 773.78M | $ 732.98M | $ 520.39M |
| Operating Cash Flow | $ 1.40B | $ 1.09B | $ 1.27B | $ 778.51M | $ 899.65M |
| Investing Cash Flow | $ -508.19M | $ -163.06M | $ -446.23M | $ -5.21B | $ -1.01B |
| Financing Cash Flow | $ 20.52M | $ -305.25M | $ -529.49M | $ 3.97B | $ 528.07M |